Trial Outcomes & Findings for Enhancing Skin Cancer Early Detection and Treatment in Primary Care (NCT NCT05675709)

NCT ID: NCT05675709

Last Updated: 2025-12-08

Results Overview

KnChange in melanoma risk, knowledge based upon survey questions prior to training and post-training. Content covered melanoma risk, knowledge of electronic health record tools specific to the training and lesion identification and biopsy procedure knowledge. A total score of correct responses for the 27 items was generated and transformed to represent the percent of correct items with zero being no correct items and 100% being all items correct. A change score from pre-training to post-training was generated where a positive change score represented the gain in knowledge in percent points and a negative change score representing a lower percent of correct responses from pre-training to post-training.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

54 participants

Primary outcome timeframe

Immediately before and after the training session

Results posted on

2025-12-08

Participant Flow

Forty-five clinicians (physicians, PAs, and NPs) received an email inviting them to participate in the MelaNOma training. Seventeen participated in the training. A total of 37 clinicians who weren't invited or chose not to participate in the MelaNOma training session were assigned to the comparator group. The total study sample size is 54.

Participant milestones

Participant milestones
Measure
Melanoma Training Group
MelaNOma included a 40-minute hybrid training co-led by a family medicine physician and a dermatologist
Comparison Group
Clinicians from the same 2 clinics who weren't invited or chose not to participate in the MelaNOma training session
Overall Study
STARTED
17
37
Overall Study
COMPLETED
15
29
Overall Study
NOT COMPLETED
2
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Melanoma Training Group
MelaNOma included a 40-minute hybrid training co-led by a family medicine physician and a dermatologist
Comparison Group
Clinicians from the same 2 clinics who weren't invited or chose not to participate in the MelaNOma training session
Overall Study
incomplete outcome data
2
8

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Comparison Group
n=29 Participants
PCPs at the two clinics who do not receive the group training will serve as study comparators.
Training Group
n=15 Participants
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. Training and Education: Undergo group trainings
Total
n=44 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=29 Participants
0 Participants
n=15 Participants
0 Participants
n=44 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
n=29 Participants
15 Participants
n=15 Participants
44 Participants
n=44 Participants
Age, Categorical
>=65 years
0 Participants
n=29 Participants
0 Participants
n=15 Participants
0 Participants
n=44 Participants
Sex: Female, Male
Female
18 Participants
n=29 Participants
10 Participants
n=15 Participants
28 Participants
n=44 Participants
Sex: Female, Male
Male
11 Participants
n=29 Participants
5 Participants
n=15 Participants
16 Participants
n=44 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
29 participants
n=29 Participants
15 participants
n=15 Participants
44 participants
n=44 Participants

PRIMARY outcome

Timeframe: Immediately before and after the training session

Population: Knowledge was assessed before and after the training session for those clinicians who attended the training. We conducted a paired t-test

KnChange in melanoma risk, knowledge based upon survey questions prior to training and post-training. Content covered melanoma risk, knowledge of electronic health record tools specific to the training and lesion identification and biopsy procedure knowledge. A total score of correct responses for the 27 items was generated and transformed to represent the percent of correct items with zero being no correct items and 100% being all items correct. A change score from pre-training to post-training was generated where a positive change score represented the gain in knowledge in percent points and a negative change score representing a lower percent of correct responses from pre-training to post-training.

Outcome measures

Outcome measures
Measure
Comparison group
PCPs at the two clinics who do not receive the group training will serve as study comparators.
Training group
n=10 Participants
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. Training and Education: Undergo group trainings
Change in Clinician Knowledge in Melanoma Risk and Lesion Identification
Immediately before the training
72.1 score on a scale
Standard Deviation 7.2
Change in Clinician Knowledge in Melanoma Risk and Lesion Identification
Immediately after the training
80.8 score on a scale
Standard Deviation 9.6

PRIMARY outcome

Timeframe: minimum of 3 months and up to 1 year of EHR data for each clinician prior to the start of the training and the same months in the year post-training.

Mean percent of dermatology referrals per 1000 patients

Outcome measures

Outcome measures
Measure
Comparison group
n=29 Participants
PCPs at the two clinics who do not receive the group training will serve as study comparators.
Training group
n=15 Participants
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. Training and Education: Undergo group trainings
Dermatology Referral
pre-training period
13.8 percent per 1000 patients
Standard Deviation 9.2
16.9 percent per 1000 patients
Standard Deviation 9.0
Dermatology Referral
post-training period
14.1 percent per 1000 patients
Standard Deviation 11.1
11.4 percent per 1000 patients
Standard Deviation 6.7

PRIMARY outcome

Timeframe: minimum of 3 months and up to 1 year of EHR data for each clinician prior to the start of the training and the same months in the year post-training.

number of dermatology e-consults

Outcome measures

Outcome measures
Measure
Comparison group
n=29 Participants
PCPs at the two clinics who do not receive the group training will serve as study comparators.
Training group
n=15 Participants
PCP participants complete group training. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview. Training and Education: Undergo group trainings
Use of Dermatology E-consults
pre-training period
5.1 percent per 1000 patients
Standard Deviation 7.8
5.5 percent per 1000 patients
Standard Deviation 7.8
Use of Dermatology E-consults
post-training period
7.2 percent per 1000 patients
Standard Deviation 9.2
7.8 percent per 1000 patients
Standard Deviation 7.5

Adverse Events

Comparison group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Training group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Susan Flocke

Oregon Health & Science University

Phone: 503 494 4404

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place